Cargando…
Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection
There is a significant prevalence (20%–80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatment–associated metabolic and cardiovascular concerns, including dyslipidemias,...
Autor principal: | Troll, J. Gregory |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018260/ https://www.ncbi.nlm.nih.gov/pubmed/21181310 http://dx.doi.org/10.1007/s11883-010-0152-1 |
Ejemplares similares
-
Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil
por: Papi, Luanda, et al.
Publicado: (2014) -
Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania, Rohit, et al.
Publicado: (2011) -
The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
por: Sutinen, Jussi
Publicado: (2009) -
New and emerging agents in the management of lipodystrophy in HIV-infected patients
por: Bonnet, Eric
Publicado: (2010) -
Body composition and lipodystrophy in prepubertal HIV-infected children
por: Palchetti, Cecilia Zanin, et al.
Publicado: (2013)